TITLE

Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000

AUTHOR(S)
Pérez-Farinós, Napoleón; López-Abente, Gonzalo; Pastor-Barriuso, Roberto
PUB. DATE
January 2006
SOURCE
BMC Public Health;2006, Vol. 6 Issue 1, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The incorporation of diagnostic and therapeutic improvements, as well as the different smoking patterns, may have had an influence on the observed variability in renal cancer mortality across Europe. This study examined time trends in kidney cancer mortality in fourteen European countries during the last two decades of the 20th century. Methods: Kidney cancer deaths and population estimates for each country during the period 1981-2000 were drawn from the World Health Organization Mortality Database. Age- and period-adjusted mortality rates, as well as annual percentage changes in age-adjusted mortality rates, were calculated for each country and geographical region. Log-linear Poisson models were also fitted to study the effect of age, death period, and birth cohort on kidney cancer mortality rates within each country. Results: For men, the overall standardized kidney cancer mortality rates in the eastern, western, and northern European countries were 20, 25, and 53% higher than those for the southern European countries, respectively. However, age-adjusted mortality rates showed a significant annual decrease of -0.7% in the north of Europe, a moderate rise of 0.7% in the west, and substantial increases of 1.4% in the south and 2.0% in the east. This trend was similar among women, but with lower mortality rates. Age-period-cohort models showed three different birth-cohort patterns for both men and women: a decrease in mortality trend for those generations born after 1920 in the Nordic countries, a similar but lagged decline for cohorts born after 1930 in western and southern European countries, and a continuous increase throughout all birth cohorts in eastern Europe. Similar but more heterogeneous regional patterns were observed for period effects. Conclusion: Kidney cancer mortality trends in Europe showed a clear north-south pattern, with high rates on a downward trend in the north, intermediate rates on a more marked rising trend in the east than in the west, and low rates on an upward trend in the south. The downward pattern observed for cohorts born after 1920-1930 in northern, western, and southern regions suggests more favourable trends in coming years, in contrast to the eastern countries where birth-cohort pattern remains upward.
ACCESSION #
29362265

 

Related Articles

  • ATC/DDD Classification (final).  // WHO Drug Information;2001, Vol. 15 Issue 3/4, p174 

    Presents United Nations World Health Organization final anatomical therapeutic chemical (ATC) classifications and defined daily doses. ATC level codes; Common names; ATC code.

  • ATC/DDD Classification (temporary).  // WHO Drug Information;2001, Vol. 15 Issue 3/4, p177 

    Presents United Nations World Health Organization temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses. ATC level codes; Common names; ATC code.

  • Essential Medicines.  // WHO Drug Information;2002, Vol. 16 Issue 2, p138 

    Presents the World Health Organization model list of essential medicines, revised in April 2002. Anesthetics; Antiallergics and medicines used in anaphylaxis; Antidotes; Antimigraine medicines.

  • International Nonproprietary Names for Pharmaceutical Substances (INN).  // WHO Drug Information;2002, Vol. 16 Issue 2, p157 

    Presents a list of Proposed and Recommended International Nonproprietary Names for pharmaceutical substances under consideration by the World Health Organization.

  • PROCEDURE FOR THE SELECTION OF RECOMMENDED INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES.  // WHO Drug Information;2002, Vol. 16 Issue 2, p194 

    Presents the procedure for the selection of recommended International Nonproprietary Names for pharmaceutical substances under consideration by the World Health Organization.

  • GENERAL PRINCIPLES FOR GUIDANCE IN DEVISING INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES.  // WHO Drug Information;2002, Vol. 16 Issue 2, p195 

    Presents the general principles for guidance in devising International Nonproprietary Names for pharmaceutical substances under consideration by the World Health Organization.

  • Policy guidelines on controlled substances.  // WHO Drug Information;2011, Vol. 25 Issue 3, p132 

    The article reports that in 2011 the World Health Organization's Access to Controlled Medicines Team has published a book titled “Ensuring Balance in National Policies on Controlled Substances: Guidance for Availability and Accessibility for Controlled Medicines”.

  • List of medicines to save mothers and children.  // WHO Drug Information;2011, Vol. 25 Issue 3, p133 

    The article reports that in 2011 the World health Organization released a document which contains a list of 30 of the most important essential medicines for mothers and children.

  • World medicines situation.  // WHO Drug Information;2011, Vol. 25 Issue 3, p133 

    The article reports that in 2011 the World Health Organization released the third edition of its "World Medicines Situation Report 2011,” a report which offers new data on 24 key topics relating to pharmaceuticals.

  • Registration of coding schemes used in health care communications.  // Bulletin of the World Health Organization;1995, Vol. 73 Issue 6, p806 

    Reports on the World Health Organization's acceptance of a proposal for it to act as a Registration Authority in support of the European Prestandard ENV 1068 for coding schemes used in health care information interchange. Use of a set of identifiers for coding schemes; Bodies responsible for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics